Riskpilot← Back to searchSign inGet full accessAydin Hälsa AB
ABActiveOrg 5569643488Kantyxegatan 10Medical specialists activities · NACE 8622Est. 20141-4 employees
Revenue 2025
SEK 2,9M
-3% vs 2024
EBITDA margin
27.1%
-14% vs 2024
Equity ratio
59.7%
Financial strength
Net profit 2025
SEK 580K
-16% vs 2024
| Revenue | SEK 2,9M | -3% |
| EBITDA | SEK 785K | -14% |
| Net profit | SEK 580K | -16% |
| Total assets | SEK 1,4M | -1% |
| Equity | SEK 862K | -18% |
| Employees | — | — |
Legal name
Aydin Hälsa AB
Org number
5569643488
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
6 mars 2014
Share capital
SEK 50 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas ensam av Ahmadi, Farzad
Company purpose
Specialistläkare, behandlingsuppdrag, inom öppenvård, på sjukhus. Företaget erbjuder specialistläkartjänster till andra vårdenheter både privat och offentlig sektor. Bolaget hyr ut läkare inom psykiatrisk vård samt därmed förenlig verksamhet. Företaget hyr även ut personal till andra företag inom olika branscher.
Address
Kantyxegatan 10
Email
drfarzad_ahmadi@yahoo.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 2 727 | 2 896 | 2 888 | 2 975 | 2 898 |
| Staff expenses | — | −1 715 | −1 495 | −1 525 | −1 756 |
| EBITDA | 600 | 810 | 977 | 908 | 785 |
| Depreciation & amort. | −0 | — | — | — | −53 |
| EBIT | 600 | 810 | 977 | 908 | 733 |
| Net financials | — | −0 | 1 | 15 | 2 |
| Profit before tax | 550 | 810 | 978 | 873 | 734 |
| Tax | −118 | −178 | −204 | −182 | −154 |
| Net profit | 432 | 632 | 774 | 690 | 580 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 013 | 1 671 | 2 018 | 1 456 | 1 443 |
| Equity | 772 | 904 | 1 178 | 1 048 | 862 |
| Long-term debt | 0 | −4 | −12 | 0 | — |
| Short-term debt | 240 | 770 | 852 | 407 | 581 |
| Total debt | 240 | 766 | 840 | 407 | 581 |
EBITDA margin
27.1%
This company
15.8%
Market median
+72% vs market
20212025
Equity ratio
59.7%
This company
38.2%
Market median
+56% vs market
20212025
Return on equity
67.3%
This company
18.4%
Market median
+266% vs market
20212025
Net profit margin
20.0%
This company
8.1%
Market median
+147% vs market
20212025
Asset turnover
2.01×
This company
1.12×
Market median
+79% vs market
20212025
Debt / equity
0.67×
This company
0.62×
Market median
+8% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2020 | |
| Board of Directors | 2020 | |
| Former (1) | ||
| Board of Directors | 2020 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Aydin Hälsa AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tina Ahmadi | Deputy Board Member | 0 companies |
| Farzad Ahmadi | Board of Directors | 0 companies |
| Majid Micke Rezadost | Board of Directors | 0 companies |